750 results
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
-FX* Closed Four Significant Deals No change to the underlying business outlook from February 2024 Strengthened long-term growth profile … by long-term data2,3,4 U.S. FDA PDUFA date September 26, 2024; Launch preparations underway 1. DRG – Clarivate, as of July 2023; 2. Kaul I, et al. SIRS
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
the Company's Long-Term Growth Profile
First Quarter Revenues were $11.9 Billion, increasing 5% (+6% Adjusting for Foreign Exchange)
◦Growth Portfolio … Revenues were $4.8 Billion, increasing 8% (+11% Adjusting for Foreign Exchange)
Strengthened Long-Term Growth Profile Through Completion of Karuna
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
spend with diverse- diverse metro areas owned businesses ENVIRONMENTAL RESPONSIBILITY Submitted near-term and long-term (net zero by 2050) Science … results and delivered in the form of equity, supporting alignment over the long term between our executives and our shareholders Competitive Pay Program
8-K
EX-1.1
496c3u
22 Feb 24
Other Events
4:15pm
424B5
005nk pkit18
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
2iixf7aaa6dd0l
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
3bwuyh f7z
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.2
6pob kvtuj
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
yx7nfthwytduezw22
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
teoesv90v
8 Jan 24
Regulation FD Disclosure
10:29am
8-K
EX-1.1
reqo n3c96e0fd
13 Nov 23
Other Events
4:19pm
424B5
c81e 26rpecba
1 Nov 23
Prospectus supplement for primary offering
4:16pm
8-K/A
605t6scl
31 Oct 23
Departure of Directors or Certain Officers
4:30pm
424B3
jzuyn n8gat9kq66o
30 Oct 23
Prospectus supplement
8:05am